5 Things Egg Donor Ads Bury Under the Big Dollar Sign, From OHSS Odds to a Shrug on Long-Term Data

mygiftedegg ยท September 29, 2026

You donated 16 eggs.

The ad promised $10,000 within 90 days.

Five months later, you're still waiting.

That ad printed the number in bold.

It could have printed the risk in bold too.

Here are five things it buried.

1. The OHSS odds

One study of recruitment ads found that 86.4% never mention OHSS.

That's ovarian hyperstimulation.

Your own case manager may have sworn it never happens at that clinic.

One donor was told exactly that.

Hyperstimulation "had never happened" there.

Weeks later, it happened to her.

An agency's own promotional material calls serious OHSS "less than 2%."

A researcher's donor data shows critical, hospitalization-level cases.

Both can't be the whole picture.

Honest recruitment would print the number, say who calculated it, and say where the donor reports disagree.

A broke college student might assume a flyer couldn't skip something dangerous.

It can.

One donor described it afterward: "couldn't believe how in the dark" she was.

She had signed informed consent paperwork.

So what happens when the risk is real, and the ad still stays quiet?

2. The hospital stay

Donors describe internal bleeding and nearly losing an ovary.

One spent four days in intensive care after a second retrieval of 53 eggs.

Her first bad cycle had been called "uncommon."

Another said her abdomen swelled to "the size of a basketball."

Walking was hard.

None of that fit the ads.

Donors say the pitch leaned on ease and lifestyle, handbags and trips.

A smooth first cycle promised nothing about the second.

Yet the fee climbs anyway.

One repeat donor watched hers go from $6,000 to $10,000, then higher.

Another was offered $25,000 for a fourth cycle, framed as a reward for being "proven."

ASRM's own six-cycle limit exists because of cumulative risk.

The premium prices that risk, and the ad calls it a bonus.

If you've been through this, you know the ad skipped the hospital.

Honest copy would put it beside the payout.

And the biggest gap of all is what nobody has measured.

3. The shrug on long-term data

Another 83.5% of ads don't mention long-term risks at all.

Some do offer a line.

"No known long-term risk."

That sentence is technically true.

It's true because nobody ever looked.

One donor learned this only after researching on her own.

Her clinic's "no reported long-term harm" meant no one had studied it.

If you think agency materials are built to reassure, you're reading them correctly.

A clinic can cite the absence of studies.

It can't cite proof of safety.

Honest recruitment would say it plainly.

"Nobody has followed donors long enough to know."

One donor turned down $80,000 to $100,000 for a single cycle.

The money seemed too big for risk no one would explain.

The dollar figure itself has gaps too, and you know that one personally.

4. Promised versus paid

The bold number rarely says what it's promised against.

Is it per donation or per egg?

What changes if fewer eggs come out?

What happens if the cycle is cancelled or the donor is disqualified after medication starts?

Ads don't say.

Donors find out later.

Per diems can run only $50 to $75 a day.

Travel eats into the total.

A two-week commitment can stretch to eight weeks or more.

Some donors learn only after signing that the money is taxable.

One had to donate again to cover the bill.

Then there's the payment itself.

You were told 90 days.

You did the injections, the retrieval, all of it.

Now you have vague answers about processing delays.

A donor who backed out before any injections began was billed $3,400 for "screening and exam costs."

Payment moved one way when it was owed to her, and another when it was owed by her.

Honest copy would print the timeline, the cancellation terms, and the tax hit.

Right beside the headline figure.

So who was supposed to hold anyone to that number?

5. Who actually holds the cap

Ask what governs the $10,000 figure and you get three answers.

A law, a guideline, or agency policy.

It was a guideline.

ASRM withdrew it after a legal challenge.

Agencies now pay what the market bears.

One agency says it caps pay at $10,000 and calls $100,000 offers "incredibly rare."

Other reporting suggests such sums circulate regularly.

In one study, 8 of 11 ads offering over $20,000 targeted women under 21.

You believed a promise made in an ad has no teeth.

The record so far doesn't argue with you.

Which leaves the question sitting in your chest.

If you keep speaking up, what happens to them, and do you look difficult to the next agency?

I can't promise the clinic pays.

I can tell you what silence has done.

Donors say real risk disclosure only happens in forums and comment threads, after the signing.

Your post is that disclosure.

It's the paragraph the ad left out.

An agency that would blacklist a woman for telling the truth about promised versus paid is the one whose ad needed that paragraph most.

The clinic turned off the comments.

The next woman is reading a flyer right now.